Acceleron Pharma Inc. [·] Shares (1) Common Stock ($0.001 par value) Underwriting AgreementAcceleron Pharma Inc • January 21st, 2014 • Biological products, (no disgnostic substances) • New York
Company FiledJanuary 21st, 2014 Industry JurisdictionCitigroup Global Markets Inc. Leerink Partners LLC As Representatives of the several Underwriters, c/o Citigroup Global Markets Inc. 388 Greenwich Street New York, New York 10013
ACCELERON PHARMA INC. NON-STATUTORY STOCK OPTION AGREEMENTNon-Statutory Stock Option Agreement • January 21st, 2014 • Acceleron Pharma Inc • Biological products, (no disgnostic substances)
Contract Type FiledJanuary 21st, 2014 Company IndustryThis agreement (this “Agreement”) evidences a stock option granted by Acceleron Pharma Inc. (the “Company”) to the undersigned (the “Optionee”) pursuant to and subject to the terms of the Acceleron Pharma Inc. 2013 Equity Incentive Plan (as amended from time to time, the “Plan”).
ACCELERON PHARMA INC. INCENTIVE STOCK OPTION AGREEMENTEquity Incentive Plan • January 21st, 2014 • Acceleron Pharma Inc • Biological products, (no disgnostic substances)
Contract Type FiledJanuary 21st, 2014 Company IndustryThis agreement (this “Agreement”) evidences a stock option granted by Acceleron Pharma Inc. (the “Company”) to the undersigned (the “Optionee”) pursuant to and subject to the terms of the Acceleron Pharma Inc. 2013 Equity Incentive Plan (as amended from time to time, the “Plan”).